Current Projects

(The links below will be redirected to our US partner fpwr.org)

Current Projects Funded by FPWR Canada

  • REVEALING THE MOLECULAR ARCHITECTURE OF PWS THROUGH LARGE LANGUAGE MODELS FOR TARGETED DRUG REPURPOSING

    Year: 2024
    Investigator: Dr. Rohit Singh
    Location: Ohio State University
    Amount in CAD Funds: $65,000.00

  • Using Functional Near-Infrared Spectroscopy to Identify Biomarkers of Skin Picking Behavior in PWS

    Year: 2023
    Investigator: Dr. Scott Hall
    Location: Stanford University
    Amount in CAD Funds: $90,000.00

  • The Role of Microglia in Prader-Willi Syndrome and a Hypothalamic Gene Therapy

    Year: 2023
    Investigator: Dr. Lei Cao
    Location: Ohio State University
    Amount in CAD Funds: $90,000.00

  • Unraveling the Mechanism of PWS by Molecular Dissection of Driver Genes in Hypothalamic Neuron Model, Year 2

    Year: 2022
    Investigator: Dr. Derek Tai
    Location: University of Michigan
    Amount in CAD Funds: $146,222.00

  • Determining Beloranib’s Mechanism of Action to Inform Novel Drug Targets for PWS

    Year: 2022
    Investigator: Dr. Sarah Mitchell
    Location: ETH Zurich
    Amount in CAD Funds: $146,222.00

  • Unraveling the Mechanism of PWS by Molecular Dissection of Driver Genes in Hypothalamic Neuron Model, Year 2

    Year: 2021
    Investigator: Dr. Derek Tai
    Location: Massachusetts General Hospital
    Amount in CAD Funds: $149,018.00

  • Role of MAGEL2 in Excitatory Synapse Function – PWS gene effects on oxytocin and brain cell communication

    Year: 2020
    Investigator: Dr. Deniz Atasoy
    Location: University of Iowa
    Amount in CAD Funds: $84,838.00

  • Neuronal Mechanisms of Developmental Cognitive Impairment in the SNORD116Del Mouse Model for Prader-Willi Syndrome – How neurons develop differently in PWS

    Year: 2020
    Investigator: Dr. Timothy Wells
    Location: Cardiff University
    Amount in CAD Funds:   $4,713.00

  • Allele-Specific DNA Replication Timing of the Prader-Willi Locus and its Influence on Neuronal Development – Brain cell replication in PWS has defective DNA, which might cause some of the PWS developmental effects

    Year: 2020
    Investigator: Dr. Amnon Koren
    Location: Cardiff University
    Amount in CAD Funds: $70,698.00

  • Investigating a new potential target for treatment in Prader-Willi Syndrome

    Year: 2019
    Investigator: Dr. Lauren Rice
    Location: University of Sydney
    Amount in CAD Funds:   $200,428.00

  • Understanding the role of microglia in the Prader-Willi Hypothalamus

    Year: 2018
    Investigator: Dr. Deborah Kurrasch
    Location: University of Calgary
    Amount in CAD Funds: $142,461.00

  • Chronic Stress, cognition, and food cue reactivity in PWS: A Magnetoencephalography study Year: 2018

    Year: 2018
    Investigator: Dr. Jill Hamilton
    Location: Hospital for Sick Children Toronto
    Amount in CAD Funds: $147,689.00

  • Systematic Investigation of Early Social Cognitive Processes and the Feasibility of Intervention Year: 2017

    Year: 2017
    Investigator: Dr. Anastasia Dimitropoulos
    Location: Case Western University, Ohio
    Amount in CAD Funds: $100,252.00

  • Dissecting a novel brainstem feeding circuit in Prader-Willi Syndrome

    Year: 2017
    Investigator: Alexander Nectow
    Location: Princeton University
    Amount in CAD Funds: $135,389.00

  • A Mindfulness-based intervention for temper outbursts in Prader-Willi Syndrome.

    Year: 2017
    Investigator: Stewart Einfeld
    Location: University of Sydney, Australia
    Amount in CAD Funds: $60,766.00

  • Improving social functioning in Prader-Willi syndrome

    Year: 2017
    Investigator: Elisabeth Dykens
    Location: Vanderbilt University
    Amount in CAD Funds: $147,538.00

  • Therapeutic Potential of Blocking Zinc Finger Protein 274 Binding to the PWS Locus

    Year: 2017
    Investigator: Marc Lalande, PhD
    Location: University of Connecticut Health Center
    Amount in CAD Funds: $72,842.00

  • Mitochondrial Complex I dysfunction in Prader Willi Syndrome: A new therapeutic target

    Year: 2016
    Investigator: Dr. Ingrid Tein 
    Location: Hospital for Sick Kids, Toronto 
    Amount in CAD Funds: $71,555.00

  • Impact of carbohydrate restricted diet upon growth and hyperphagia/food anxiety in children with Prader-Willi Syndrome

    Year: 2016
    Investigator: Ann Scheimann, MD
    Location: Johns Hopkins University
    Amount in CAD Funds:  $150,514.00

  • Loss of MAGEL2 and hypotonia in Prader-Willi Syndrome

    Year: 2016
    Investigator: Rachel Wevrick, PhD
    Location: University of Alberta
    Amount in CAD Funds: $111,821.00

  • Role of melanin concentrating hormone in an animal model of Prader-Willi Syndrome

    Year: 2015
    Investigator: Michiru Hirasawa, DVM, PhD
    Location: Memorial University of Newfoundland, St. John’s
    Amount in CAD Funds: $84,000.00

  • Characterisation of anti-ghrelin autoantibodies in Prader-Willi Syndrome

    Year: 2015
    Investigator: Lisa Chopin, DVM, PhD
    Location: Queensland University of Technology, Australia
    Amount in CAD Funds:  $158,431.00

  • Reactivation of the PWS locus via disruption of the ZNF274 silencing complex

    Year: 2014
    Investigator: Marc Lalande, PhD
    Location: University of Connecticut Health Center
    Amount in CAD Funds:  $129,027.00

  • Small Molecules and Therapeutic Potential for PWS

    Year: 2014
    Investigator:  Yong-Hui Jiang,PhD
    Location: Duke University, Durham NC
    Amount in CAD Funds: $21,710.00